Loading clinical trials...

Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation. | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT06724250

Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.

assessment the Improvement symptoms of obstructed defecation after biofeedback training versus botulinum toxin injection

Lead sponsor: Mansoura University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Obstructed Defaecation: Proctography Versus Ultrasound in Symptomatic Patients

NCT02239302 · Obstructed Defaecation Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment78

Start dateAug 2023

Last updatedDec 9, 2024

Condition

Obstructed Defaecation Syndrome

Locations shown

Mansoura faculty of medicine

Al Mansurah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions